Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000460199 | SCV000550879 | uncertain significance | Familial hypertrophic cardiomyopathy 11; Dilated cardiomyopathy 1R; Atrial septal defect 5 | 2018-01-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys20Argfs*38) in the ACTC1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs730880387, ExAC 0.002%). This variant has not been reported in the literature in individuals with ACTC1-related disease. ClinVar contains an entry for this variant (Variation ID: 180752). The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in ACTC1 cause disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Clinical Molecular Genetics Laboratory, |
RCV000678694 | SCV000804856 | uncertain significance | not specified | 2015-07-29 | no assertion criteria provided | clinical testing |